Edition:
United States

Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,978.00GBp
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
2,978.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
236,414
52-wk High
3,032.00
52-wk Low
1,666.00

Chart for

About

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The... (more)

Overall

Beta: 0.54
Market Cap(Mil.): £3,018.72
Shares Outstanding(Mil.): 102.33
Dividend: 7.33
Yield (%): --

Financials

  DPH.L Industry Sector
P/E (TTM): 64.20 29.26 33.20
EPS (TTM): 0.46 -- --
ROI: 7.80 13.66 13.23
ROE: 14.42 15.51 15.28

BRIEF-Dechra Pharmaceuticals Says HY Revenue Up 11 Pct

* SAYS REPORTED GROUP REVENUE FOR SIX MONTHS ENDED 31 DECEMBER 2017 INCREASED BY 11.2% AT CONSTANT EXCHANGE RATE

Feb 26 2018

BRIEF-Dechra Pharmaceuticals ‍Raises 105 Mln Stg Via Placing

* ‍ANNOUNCES SUCCESSFUL COMPLETION OF PLACING ANNOUNCED EARLIER TODAY​

Jan 25 2018

UK's Dechra to buy Dutch firms AST Farma, Le Vet for $422 million

Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Le Vet for a total of 340 million euros ($422.1 million) in a cash-and-share deal to boost its presence in Europe.

Jan 25 2018

UPDATE 1-UK's Dechra to buy Dutch firms AST Farma, Le Vet for $422 mln

Jan 25 Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Le Vet for a total of 340 million euros ($422.1 million) in a cash-and-share deal to boost its presence in Europe.

Jan 25 2018

UK's Dechra to buy Dutch firms AST Farma, Le Vet for 340 mln euros

Jan 25 Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros ($422.1 million) in a cash and share deal.

Jan 25 2018

BRIEF-Dechra Pharmaceuticals to acquire Ast Farma and Le Vet

* ‍BOARD OF DECHRA, INTERNATIONAL VETERINARY PHARMACEUTICAL BUSINESS, IS PLEASED TO ANNOUNCE THAT IT HAS ENTERED INTO A CONDITIONAL ACQUISITION AGREEMENT TO ACQUIRE AST FARMA AND LE VET FOR A TOTAL CONSIDERATION OF EUR 340.0 MILLION ON A DEBT-FREE AND CASH-FREE BASIS​

Jan 25 2018

Earnings vs. Estimates